Monitoring of platelet function parameters and microRNA expression levels in patients with prostate cancer treated with volumetric modulated arc radiotherapy-Reference-Cited by-同舟云学术

Monitoring of platelet function parameters and microRNA expression levels in patients with prostate cancer treated with volumetric modulated arc radiotherapy

Published:2018-07-18 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Bahtiyar Nurten¹,Onaran İlhan²,Aydemir Birsen³,Baykara Onur²,Toplan Selmin¹,Agaoglu Fulya⁴,Akyolcu Mehmet¹

Affiliation:

1. Department of Biophysics, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul 34098, Turkey

2. Department of Medical Biology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul 34098, Turkey

3. Department of Biophysics, Faculty of Medicine, Sakarya University, Sakarya 54050, Turkey

4. Department of Radiation Oncology, Institute of Oncology, Istanbul University, Istanbul 34098, Turkey

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of microRNAs following radiation therapy and association with severity of radiotherapy‑induced toxicity among patients with prostate adenocarcinoma: A systematic review and meta‑analysis;World Academy of Sciences Journal;2024-04-04

2. Impact of Stereotactic Body Radiotherapy on Thrombin Generation and Platelet Aggregation in Patients with Non-Small Cell Lung Cancer;Clinical and Applied Thrombosis/Hemostasis;2023-01

3. Reference Results for Blood Parameter Changes and Recovery after Pelvic Radiation without Chemotherapy;Hematology Reports;2022-05-12

4. New Insights Into Platelet-enriched miRNAs: Production, Functions, Roles in Tumors, and Potential Targets for Tumor Diagnosis and Treatment;Molecular Cancer Therapeutics;2021-05-27

5. VMAT for prostate cancer with 6‑MV and 10‑MV photons: Impact of beam energy on treatment plan quality and model‑based secondary cancer risk estimates;Molecular and Clinical Oncology;2021-03-05